Share on LinkedInShare on LinkedIn

ARTICLE · 11 OCTOBER 2019

Canadian Class Action Commenced Against Breast Implant Manufacturer Allergan

In spite of having this knowledge, the defendants have failed to warn Canadian patients adequately or at all about these risks and have still not recalled the Allergan Implants in Canada.

CanadaLitigation, Mediation & Arbitration

On May 23, 2019, Thomson Rogers and Rochon Genova LLP issued a class action on behalf of Canadians who were implanted with breast implants manufactured and distributed by Allergan plc and several of its affiliates.

The proposed Canada-wide class action, filed with the Ontario Superior Court of Justice, alleges, among other things, that the defendants knew or ought to have known that the Allergan Implants were associated with breast implant-related illnesses, including several autoimmune, musculoskeletal and neurological disorders, numerous cognitive adverse health effects, as well as the development of breast-implant associated anaplastic large cell lymphoma ("BIA-ALCL"). In spite of having this knowledge, the defendants have failed to warn Canadian patients adequately or at all about these risks and have still not recalled the Allergan Implants in Canada.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from